BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020

Haitham Hamoda, Susan R. Davis, Antonio Cano, Edward Morris, Sonia Davison, Nicholas Panay, Mary A. Lumsden, Tim Hillard, Tommaso Simoncini

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Number of pages7
JournalPost Reproductive Health
Publication statusAccepted/In press - 17 Jan 2021
Externally publishedYes

Cite this